Characteristic | N | % |
---|---|---|
Median age, years | 61 | Â |
Age range, years | 32–84 |  |
Sex | Â | Â |
   Male | 53 | 48 |
   Female | 58 | 52 |
NSCLC stage | Â | Â |
   IIIa | 23 | 21 |
   IIIb | 36 | 32 |
   IV | 52 | 47 |
ECOG performance | Â | Â |
   0 | 51 | 46 |
   1 | 52 | 47 |
   2 | 7 | 6 |
   Missing | 1 | 1 |
Baseline neutrophils ≥ 4.5 |  |  |
   Yes | 90 | 81 |
   No | 21 | 19 |
Tumour Histology | Â | Â |
   Adenocarcinoma | 58 | 52 |
   All other | 53 | 48 |
Bone metastases | Â | Â |
   Yes | 17 | 15 |
   No | 90 | 81 |
   Missing | 4 | 4 |
Chemotherapy regimens | Â | Â |
   Carboplatin based | 87 | 78 |
   Cisplatin based | 4 | 4 |
   Other | 20 | 18 |